Complete a secure clinical form. A doctor reviews it and may call you briefly before prescribing. This page explains when an online prescription request can fit, what information the doctor needs, what it costs, and when in-person care is safer.
Full refund if the doctor declines. A prescription is never promised. The doctor may call, message, decline, or recommend in-person care.
Cost
$29.95
One-off repeat prescription review. Pharmacy cost is separate if a prescription is approved.
Timing
Form first
Requests submit 24/7. Prescription review operates 8am-10pm AEST, 7 days, and depends on clinical detail.
Boundary
Repeat only
For medicines you already take. New, unclear, urgent, or complex requests need another pathway.
The useful part of telehealth is not skipping judgement. It is giving the doctor the right information quickly enough to decide whether remote care is appropriate.
Use the label, old prescription, pharmacy app, or GP record so the medicine name, strength, dose, and timing are not guessed. The secure form asks for the detail privately, not in the public URL.
The form asks about your medical conditions, allergies, other medicines, recent monitoring, pregnancy or breastfeeding context where relevant, and whether anything has changed since the last prescription.
An AHPRA-registered Australian doctor reviews the request. They may approve, message or call for more information, decline, or recommend in-person care.
If the doctor decides a prescription is clinically appropriate, an electronic prescription token can be sent by SMS or email for use at your chosen pharmacy.
Repeat prescription requests are narrow by design. They work best when the medicine is established, the dose is stable, and the safety picture is clear.
The public page stays medicine-neutral because Australian rules restrict advertising prescription medicines to the public. The secure form collects the private medicine details the doctor needs.
A one-off doctor review for an existing regular medicine when the history is stable and the doctor has enough information to assess safety.
Unclear medicine details, missing monitoring, new side effects, recent dose changes, or conflicting answers can lead to a call or message before any decision.
Emergency symptoms, controlled or dependence-forming medicines, complex monitoring, new treatment requests, or a request that depends on a promised result.
A repeat request can become unsafe if the condition has changed, the medicine history is unclear, monitoring is missing, or symptoms point to urgent care.
These details help the doctor decide whether a repeat prescription is reasonable or whether another care route is safer.
Call 000 for emergencies. If you are unsure whether a symptom is urgent, choose urgent care first and sort the prescription later.
The review fee is not the medicine price. The doctor decides whether prescribing is appropriate, then the pharmacy confirms dispensing, PBS eligibility, and final cost.
The repeat prescription review fee is $29.95. The fee covers doctor review, not pharmacy supply. Full refund if the doctor declines.
Medicare details are required for prescription and consultation requests because they support identity, clinical records, and electronic prescribing workflows.
If approved, the pharmacy confirms the medicine cost. PBS status, eligibility, brand choice, premiums, and pharmacy pricing can affect what you pay.
An eScript token is a link sent by SMS or email. You present it at your chosen pharmacy, or forward it to a pharmacy if they offer preparation or delivery.
These figures explain fit, boundaries, and the eScript/PBS pathway. The same labels and distinctions are also rendered below each image for accessibility and indexing.
Fit check
The best-fit request has an existing medicine, a stable dose, clear history, current monitoring where needed, and no urgent symptoms.
Care route
Red flags, unclear history, controlled or high-risk requests, and monitoring gaps can move the request out of online repeat review.
After approval
Doctor approval can create an eScript token, but the pharmacy confirms dispensing, PBS status, brand choice, and final cost.
Fit check
The best-fit request has an existing medicine, a stable dose, clear history, current monitoring where needed, and no urgent symptoms.
Care route
Red flags, unclear history, controlled or high-risk requests, and monitoring gaps can move the request out of online repeat review.
After approval
Doctor approval can create an eScript token, but the pharmacy confirms dispensing, PBS status, brand choice, and final cost.
The doctor reviews the details you provide. Online repeat prescribing is possible only when the clinical information is enough and the request is safe for remote care.
The doctor decides a prescription is clinically appropriate and sends the outcome digitally. The pharmacy still completes normal dispensing checks.
The doctor asks for clarification about medicines, monitoring, symptoms, identity, allergies, or usual-prescriber context before deciding.
The request is outside scope or not safe enough online. You are directed to a safer next step and the request is refunded.
A prescription request is not always the right first step. These pages help route stable repeats, urgent symptoms, chronic-disease context, and documentation needs.
The main service page for starting a repeat medication review.
Read moreRegular medicine renewals may be unsafe if breathing symptoms are not controlled.
Read moreStable long-term medicines often depend on monitoring and cardiovascular risk context.
Read moreDiabetes medicines often need blood test context and continuity with a regular GP.
Read moreChest pain is an urgent-care symptom, not an online prescription request.
Read moreFor short absence evidence when illness affects work or study attendance.
Read moreThis page is written for Australian patients and cites public Australian authorities where possible. Last reviewed: 2026-06.
Medical Board of Australia: Telehealth consultations with patients
National Board guidance on telehealth standards, identity, consent, records, prescribing, and when in-person care is needed.
Ahpra: Information for practitioners who provide virtual care
Professional-obligations guidance for virtual care, including suitability, patient safety, records, and prescribing cautions.
TGA: Advertising health services involving therapeutic goods
Explains why health-service advertising must avoid directly or indirectly promoting therapeutic goods.
TGA: Restrictions on advertising prescription medicines to the public
Guidance on avoiding public advertising that implies access to specific prescription medicines or medicine classes.
Australian Digital Health Agency: Electronic prescriptions
Patient information on electronic prescription tokens, pharmacy use, repeats, and Active Script List options.
Pharmaceutical Benefits Scheme: About the PBS
Australian Government information on how the PBS subsidises many necessary medicines for Australians.
Healthdirect: Medicines information
Australian patient information on medicines, side effects, medicine questions, and safe use.
Healthdirect: Side effects of medicines
Patient advice on medicine side effects, adverse reactions, and when to speak with a doctor or pharmacist.
Static answers, also included in FAQPage structured data.
Complete the secure form. A doctor reviews the information and decides whether a prescription is clinically appropriate. No promised prescription, and contact may be needed.
Full refund if the doctor declines.
Repeat prescriptions - Doctor-reviewed · Review timing 8am-10pm AEST